As the role of metabolic reprogramming had been described in CRC liver metastasis in a previous study, it was also noted that the metabolic change could be regulated by apoB expression levels between CRC and mCRC, which might result in worse long-term outcomes (8). This evidence concerns the gene APOB and colorectal carcinoma.